Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 51 | 0 | 6 | 0 | €705.80 | €766.92 | 8.660% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €210.90 | €294.01 | 39.408% |
| Boston Scientific | 46 | 0 | 10 | 0 | €68.50 | €72.96 | 6.506% |
| Vertex Pharmaceuticals Inc. | 45 | 2 | 6 | 0 | €395.25 | €408.36 | 3.316% |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €137.55 | €236.30 | 71.791% |
| Regeneron Pharmaceuticals Inc. | 35 | 1 | 4 | 0 | €913.80 | €959.41 | 4.992% |
| Intuitive Surgical Inc | 34 | 0 | 2 | 0 | €355.20 | €370.00 | 4.167% |
| UnitedHealth Group Inc. | 33 | 1 | 2 | 0 | €473.60 | €543.72 | 14.806% |
| Johnson & Johnson | 32 | 1 | 3 | 0 | €140.36 | €196.74 | 40.165% |
| Pfizer Inc. | 30 | 4 | 3 | 0 | €26.30 | €40.66 | 54.628% |
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | €128.75 | €140.60 | 9.207% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €119.80 | €124.92 | 4.276% |
| Cytokinetics Inc. | 27 | 1 | 4 | 0 | €55.00 | €85.64 | 55.715% |